scispace - formally typeset
Open AccessJournal ArticleDOI

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Reads0
Chats0
TLDR
This AASLD 2018 Hepatitis B Guidance provides a data-supported approach to screening, prevention, diagnosis, and clinical management of patients with hepatitis B.
About
This article is published in Hepatology.The article was published on 2018-04-01 and is currently open access. It has received 2399 citations till now. The article focuses on the topics: Hepatitis B & Mass screening.

read more

Citations
More filters
Journal ArticleDOI

Substantial gaps in evaluation and treatment of patients with hepatitis B in the US

TL;DR: In this paper , the proportion of patients with chronic HBV infection who received adequate evaluation, were treatment eligible, and received antiviral treatment using a large, nationwide cohort was determined.
Journal ArticleDOI

Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure.

TL;DR: It is demonstrated that the activation of the classical pathway mediated by C1q may play an important role in the pathogenesis of HBV-ACLF and the plasma levels of C3 and C3a may be potential novel biomarkers in predicting the outcome ofHBV- ACLF.
Journal ArticleDOI

Review article: current and emerging therapies for the management of cirrhosis and its complications

TL;DR: Cirrhosis is increasingly common and morbid and optimal utilisation of therapeutic strategies to prevent and control the complications of cirrhosis are central to improving clinical and patient‐reported outcomes.
Journal ArticleDOI

Viral hepatitis: Milestones, unresolved issues, and future goals

TL;DR: A review of the current overall knowledge on hepatitis A, B, C, D, and E can be found in this paper, where the authors describe the goals achieved, unresolved issues, and the latest research on this topic may make it possible to speculate on future scenarios.
References
More filters
Journal ArticleDOI

Management of hepatocellular carcinoma.

TL;DR: The prevention of Cirrhosis can prevent the development of HCC and progression from chronic HCV infection to advanced fibrosis or cirrhosis may be prevented in 40% of patients who are sustained responders to new antiviral strategies, such as pegylated interferon and ribavirin.
Journal ArticleDOI

AASLD guidelines for the treatment of hepatocellular carcinoma

TL;DR: This paper aims to demonstrate the efforts towards in-situ applicability of EMMARM, as to provide real-time information about concrete mechanical properties such as E-modulus and compressive strength.
Journal ArticleDOI

Chronic hepatitis B: Update 2009

TL;DR: The 2009 update of the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines for Management of Chronic Hepatitis B is now posted online at www.aasld.org, and the recommendation for first-line oral antiviral medications has been changed to tenofovir or entecavir, and adefovir has been moved to second-line Oral antiviral medication.
Journal ArticleDOI

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

TL;DR: More efficacious treatments, mass immunization programs, and safe injection techniques are essential for eliminating HBV infection and reducing global HBV‐related morbidity and mortality.
Related Papers (5)

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

Devin Razavi-Shearer, +195 more